Page last updated: 2024-11-02

1,2-cyclohexanediamine and Cancer of Ovary

1,2-cyclohexanediamine has been researched along with Cancer of Ovary in 2 studies

1,2-cyclohexanediamine: RN given refers to cpd without isomeric designation

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yoshida, M1
Khokhar, AR1
Siddik, ZH1
Schmidt, W1
Chaney, SG1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Phase II Study of Trastuzumab in Combination With Capecitabine and Oxaliplatin (XELOX) in Patients With Advanced Gastric Cancer[NCT01396707]Phase 255 participants (Actual)Interventional2011-06-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

2 other studies available for 1,2-cyclohexanediamine and Cancer of Ovary

ArticleYear
Biochemical pharmacology of homologous alicyclic mixed amine platinum(II) complexes in sensitive and resistant tumor cell lines.
    Cancer research, 1994, Jul-01, Volume: 54, Issue:13

    Topics: Animals; Antineoplastic Agents; Cisplatin; Cyclohexylamines; DNA, Neoplasm; Drug Resistance; Female;

1994
Role of carrier ligand in platinum resistance of human carcinoma cell lines.
    Cancer research, 1993, Feb-15, Volume: 53, Issue:4

    Topics: Antineoplastic Agents; Cisplatin; Colonic Neoplasms; Cyclohexylamines; DNA Repair; DNA, Neoplasm; Dr

1993